Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed plus Cisplatin in Refractory Soft Tissue Sarcoma
NCT03809637Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jan 2017
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in soft tissue sarcoma (STS), bone sarcoma, sponsored by Yonsei University. Started Jan 2017; status: completed.
02
Drugs
pemetrexed
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT03809637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03809637.